Figure 4From: Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model Quantification of retinal A2E. There was no difference of A2E levels in the retina between TSG-6 treated eyes (n = 7) and the untreated eyes (n = 7) two months after treatment.Back to article page